Article Cited by others

ORIGINAL ARTICLE

Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer

Puri Neelu, Salgia Ravi

Year : 2008| Volume: 7| Issue : 1 | Page no: 9-9

   This article has been cited by
 
1 TGFß can stimulate the p38/ß-catenin/PPAR? signaling pathway to promote the EMT, invasion and migration of non-small cell lung cancer (H460 cells)
Li-Chiung Lin,Shih-Lan Hsu,Chieh-Liang Wu,Chi-Mei Hsueh
Clinical & Experimental Metastasis. 2014;
[Pubmed]  [Google Scholar] [DOI]
2 The role of HER3 in gastric cancer
Liying Wang,Hengheng Yuan,Yanjing Li,Yu Han
Biomedicine & Pharmacotherapy. 2014; 68(6): 809
[Pubmed]  [Google Scholar] [DOI]
3 Study of MET protein levels andMETgene copy number in 72 sinonasal intestinal-type adenocarcinomas
Fabrice Projetti,Laura Mesturoux,Béma Coulibaly,Karine Durand,Alain Chaunavel,Sophie Léobon,Emilie Gadeaud,François Caire,Jean-Pierre Bessède,François Labrousse
Head & Neck. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]
4 Targeting c-Met in melanoma: Mechanism of resistance and efficacy of novel combinatorial inhibitor therapy
Deven Etnyre,Amanda L Stone,Jason T Fong,Ryan J Jacobs,Srijayaprakash B Uppada,Gregory M Botting,Supriya Rajanna,David N Moravec,Manohar R Shambannagari,Zachary Crees,Jennifer Girard,Ceyda Bertram,Neelu Puri
Cancer Biology & Therapy. 2014; 15(9)
[Pubmed]  [Google Scholar] [DOI]
5 Enhancement of gefitinib-induced growth inhibition by Marsdenia tenacissima extract in non-small cell lung cancer cells expressing wild or mutant EGFR
Shu-Yan Han,Hui-Rong Ding,Wei Zhao,Fei Teng,Ping-Ping Li
BMC Complementary and Alternative Medicine. 2014; 14(1): 165
[Pubmed]  [Google Scholar] [DOI]
6 Met interacts with EGFR and Ron in canine osteosarcoma
McCleese, J.K. and Bear, M.D. and Kulp, S.K. and Mazcko, C. and Khanna, C. and London, C.A.
Veterinary and Comparative Oncology. 2013; 11(2): 124-139
[Pubmed]  [Google Scholar]
7 Independent of ErbB1 gene copy number, EGF stimulates migration but is not associated with cell proliferation in non-small cell lung cancer
Lauand, C. and Rezende-Teixeira, P. and Cortez, B.A. and Niero, E.L.D.O. and Machado-Santelli, G.M.
Cancer Cell International. 2013; 13(1)
[Pubmed]  [Google Scholar]
8 Bradykinin-induced asthmatic fibroblast/myofibroblast activities via bradykinin B2 receptor and different MAPK pathways
Sabatini, F. and Luppi, F. and Petecchia, L. and Stefano, A.D. and Longo, A.M. and Eva, A. and Vanni, C. and Hiemstra, P.S. and Sterk, P.J. and Sorbello, V. and Fabbri, L.M. and Rossi, G.A. and Ricciardolo, F.L.M.
European Journal of Pharmacology. 2013; 710(1-3): 100-109
[Pubmed]  [Google Scholar]
9 Synergistic Effect of Afatinib with Su11274 in Non-Small Cell Lung Cancer Cells Resistant to Gefitinib or Erlotinib
Chen, G. and Noor, A. and Kronenberger, P. and Teugels, E. and Umelo, I.A. and De Grève, J.
PLoS ONE. 2013; 8(3)
[Pubmed]  [Google Scholar]
10 MET As a possible target for non-small-cell lung cancer
Sadiq, A.A. and Salgia, R.
Journal of Clinical Oncology. 2013; 31(8): 1089-1096
[Pubmed]  [Google Scholar]
11 Shedding of c-Met ectodomain correlates with c-Met expression in non-small cell lung cancer
Fu, L. and Guo, W. and Liu, B. and Sun, L. and Bi, Z. and Zhu, L. and Wang, X. and Leu, B. and Xie, Q. and Li, K.
Biomarkers. 2013; 18(2): 126-135
[Pubmed]  [Google Scholar]
12 Pathway Analysis for Genome-Wide Association Study of Lung Cancer in Han Chinese Population
Zhang, R. and Zhao, Y. and Chu, M. and Wu, C. and Jin, G. and Dai, J. and Wang, C. and Hu, L. and Gou, J. and Qian, C. and Bai, J. and Wu, T. and Hu, Z. and Lin, D. and Shen, H. and Chen, F.
PLoS ONE. 2013; 8(3)
[Pubmed]  [Google Scholar]
13 Association of integrin beta1 and c-MET in mediating EGFR TKI gefitinib resistance in non-small cell lung cancer
Ju, L. and Zhou, C.
Cancer Cell International. 2013; 13(1)
[Pubmed]  [Google Scholar]
14 Stage-dependent expression of PI3K/Akt-pathway genes in neuroblastoma
Fransson, S. and Abel, F. and Kogner, P. and Martinsson, T. and Ejeskär, K.
International Journal of Oncology. 2013; 42(2): 609-616
[Pubmed]  [Google Scholar]
15 A novel bispecific EGFR/Met antibody blocks tumor-promoting phenotypic effects induced by resistance to EGFR inhibition and has potent antitumor activity
R Castoldi,V Ecker,L Wiehle,M Majety,R Busl-Schuller,M Asmussen,A Nopora,U Jucknischke,F Osl,S Kobold,W Scheuer,M Venturi,C Klein,G Niederfellner,C Sustmann
Oncogene. 2013;
[Pubmed]  [Google Scholar] [DOI]
16 Enhanced suppression of proliferation and migration in highly-metastatic lung cancer cells by combination of valproic acid and coumarin-3-carboxylic acid and its molecular mechanisms of action
Xin Liu,Linlin Chen,Fujia Sun,Guoying Zhang
Cytotechnology. 2013; 65(4): 597
[Pubmed]  [Google Scholar] [DOI]
17 Association of integrin beta1 and c-MET in mediating EGFR TKI gefitinib resistance in non-small cell lung cancer
Lixia Ju,Caicun Zhou
Cancer Cell International. 2013; 13(1): 15
[Pubmed]  [Google Scholar] [DOI]
18 Bradykinin-induced asthmatic fibroblast/myofibroblast activities via bradykinin B2 receptor and different MAPK pathways
Federica Sabatini,Fabrizio Luppi,Loredana Petecchia,Antonino Di Stefano,Anna M. Longo,Alessandra Eva,Cristina Vanni,Pieter S. Hiemstra,Peter J. Sterk,Valentina Sorbello,Leonardo M. Fabbri,Giovanni A. Rossi,Fabio L.M. Ricciardolo
European Journal of Pharmacology. 2013; 710(1-3): 100
[Pubmed]  [Google Scholar] [DOI]
19 Independent of ErbB1 gene copy number, EGF stimulates migration but is not associated with cell proliferation in non-small cell lung cancer
Camila Lauand,Paula Rezende-Teixeira,Beatriz Araújo Cortez,Evandro Luís de Oliveira Niero,Gláucia Maria Machado-Santelli
Cancer Cell International. 2013; 13(1): 38
[Pubmed]  [Google Scholar] [DOI]
20 Shedding of c-Met ectodomain correlates with c-Met expression in non-small cell lung cancer
Le Fu,Wei Guo,Bingshan Liu,Linlin Sun,Zhenghong Bi,Li Zhu,Xinyan Wang,Bin Liu,Qian Xie,Ke Li
Biomarkers. 2013; 18(2): 126
[Pubmed]  [Google Scholar] [DOI]
21 Non-small cell lung cancer is susceptible to induction of DNA damage responses and inhibition of angiogenesis by telomere overhang oligonucleotides
Neelu Puri,Ryan T. Pitman,Richard E. Mulnix,Terrianne Erickson,Audra N. Iness,Connie Vitali,Yutong Zhao,Ravi Salgia
Cancer Letters. 2013;
[Pubmed]  [Google Scholar] [DOI]
22 Phosphoproteomic analysis identifies activated MET-axis PI3K/AKT and MAPK/ERK in lapatinib-resistant cancer cell line
Yong Yook Lee,Hwang-Phill Kim,Min Jueng Kang,Byoung-Kyu Cho,Sae-Won Han,Tae-You Kim,Eugene C Yi
Experimental & Molecular Medicine. 2013; 45(11): e64
[Pubmed]  [Google Scholar] [DOI]
23 The Met Receptor Tyrosine Kinase: A Key Player in Oncogenesis and Drug Resistance
Christiane R. Maroun,Tracey Rowlands
Pharmacology & Therapeutics. 2013;
[Pubmed]  [Google Scholar] [DOI]
24 Photoimmunotherapy and Irradiance Modulation Reduce Chemotherapy Cycles and Toxicity in a Murine Model for Ovarian Carcinomatosis: Perspective and Results
Imran Rizvi,Tri A. Dinh,Weiping Yu,Yuchiao Chang,Margaret E. Sherwood,Tayyaba Hasan
Israel Journal of Chemistry. 2012; 52(8-9): 776
[Pubmed]  [Google Scholar] [DOI]
25 Therapeutic potential of c-MET inhibitors: background and clinical data
Shawna Leslie Organ, J Rafael Sierra, Ming-Sound Tsao
Clinical Investigation. 2012; 2(3): 301
[HTML Full text]  [Google Scholar] [DOI]
26 Anti-tumor activity and apoptosis-regulation mechanisms of bufalin in various cancers: New hope for cancer patients
Yin, P.-H. and Liu, X. and Qiu, Y.-Y. and Cai, J.-F. and Qin, J.-M. and Zhu, H.-R. and Li, Q.
Asian Pacific Journal of Cancer Prevention. 2012; 13(11): 5339-5343
[Pubmed]  [Google Scholar]
27 Targeting the hepatocyte growth factor-cMET axis in cancer therapy
Blumenschein Jr., G.R. and Mills, G.B. and Gonzalez-Angulo, A.M.
Journal of Clinical Oncology. 2012; 30(26): 3287-3296
[Pubmed]  [Google Scholar]
28 Treatment of metastatic non-small cell lung cancer: Standard of care and future perspectives
Surmont, V. and Van Meerbeeck, J.
Minerva Pneumologica. 2012; 51(3): 117-139
[Pubmed]  [Google Scholar]
29 Anti-tumor Activity and Apoptosis-regulation Mechanisms of Bufalin in Various Cancers: New Hope for Cancer Patients
Pei-Hao Yin,Xuan Liu,Yan-Yan Qiu,Jian-Feng Cai,Jian-Min Qin,Hui-Rong Zhu,Qi Li
Asian Pacific Journal of Cancer Prevention. 2012; 13(11): 5339
[Pubmed]  [Google Scholar] [DOI]
30 Co-existence of positive MET FISH status with EGFR mutations signifies poor prognosis in lung adenocarcinoma patients
Aya Tanaka, Naoko Sueoka-Aragane, Tomomi Nakamura, Yuji Takeda, Masahiro Mitsuoka, Fumio Yamasaki, Shinichiro Hayashi, Eisaburo Sueoka, Shinya Kimura
Lung Cancer. 2011;
[HTML Full text]  [Google Scholar] [DOI]
31 The multiple roles of amphiregulin in human cancer
Benoit Busser, Lucie Sancey, Elisabeth Brambilla, Jean-Luc Coll, Amandine Hurbin
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2011;
[HTML Full text]  [Google Scholar] [DOI]
32 Risperidone-Related Improvement of Irritability in Children with Autism Is not Associated with Changes in Serum of Epidermal Growth Factor and Interleukin-13
Journal of Child and Adolescent Psychopharmacology. 2011; 21(6): 555
[HTML Full text]  [Google Scholar] [DOI]
33 Morphine-induced epidermal growth factor pathway activation in non-small cell lung cancer
Fujioka, N. and Nguyen, J. and Chen, C. and Li, Y. and Pasrija, T. and Niehans, G. and Johnson, K.N. and Gupta, V. and Kratzke, R.A. and Gupta, K.
Anesthesia and Analgesia. 2011; 113(6): 1353-1364
[Pubmed]  [Google Scholar]
34 The role of the c-Met pathway in lung cancer and the potential for targeted therapy
Sattler, M. and Hasina, R. and Reddy, M.M. and Gangadhar, T. and Salgia, R.
Therapeutic Advances in Medical Oncology. 2011; 3(4): 171-184
[Pubmed]  [Google Scholar]
35 Dual blockade of EGFR and c-Met abrogates redundant signaling and proliferation in head and neck carcinoma cells
Xu, H. and Stabile, L.P. and Gubish, C.T. and Gooding, W.E. and Grandis, J.R. and Siegfried, J.M.
Clinical Cancer Research. 2011; 17(13): 4425-4438
[Pubmed]  [Google Scholar]
36 Mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors and new therapeutic perspectives in non small cell lung cancer
Bonanno, L. and Jirillo, A. and Favaretto, A.
Current Drug Targets. 2011; 12(6): 922-933
[Pubmed]  [Google Scholar]
37 Synergistic effects of foretinib with HER-targeted agents in MET and HER1- or HER2-coactivated tumor cells
Liu, L. and Shi, H. and Liu, Y. and Anderson, A. and Peterson, J. and Greger, J. and Martin, A.-M. and Gilmer, T.M.
Molecular Cancer Therapeutics. 2011; 10(3): 518-530
[Pubmed]  [Google Scholar]
38 Primary resistance to cetuximab in a panel of patient-derived tumour xenograft models: Activation of MET as one mechanism for drug resistance
Rebekka Krumbach, Julia Schüler, Michael Hofmann, Torsten Giesemann, Heinz-Herbert Fiebig, Thomas Beckers
European Journal of Cancer. 2011; 47(8): 1231
[HTML Full text]  [Google Scholar] [DOI]
39 Morphine-Induced Epidermal Growth Factor Pathway Activation in Non–Small Cell Lung Cancer
Naomi Fujioka,Julia Nguyen,Chunsheng Chen,Yunfang Li,Teena Pasrija,Gloria Niehans,Katherine N. Johnson,Vinita Gupta,Robert A. Kratzke,Kalpna Gupta
Anesthesia & Analgesia. 2011; 113(6): 1353
[Pubmed]  [Google Scholar] [DOI]
40 Met interacts with EGFR and Ron in canine osteosarcoma : MetEGFRRon interaction in canine osteosarcoma
J. K. McCleese, M. D. Bear, S. K. Kulp, C. Mazcko, C. Khanna, C. A. London
Veterinary and Comparative Oncology. 2011; : n/a
[HTML Full text]  [Google Scholar] [DOI]
41 HGF rescues colorectal cancer cells from EGFR inhibition via MET activation
Liska, D., Chen, C.-T., Bachleitner-Hofmann, T., Christensen, J.G., Weiser, M.R.
Clinical Cancer Research. 2011; 17(3): 472-482
[Pubmed]  [Google Scholar]
42 Hepatic growth factor (HGF) inhibits cigarette smoke extract induced apoptosis in human bronchial epithelial cells
Shinsaku Togo,Hisa Sugiura,Amy Nelson,Tetsu Kobayashi,Xingqi Wang,Koh Kamio,Shin Kawasaki,Peter Bitterman,Stephen I. Rennard,Xiangde Liu
Experimental Cell Research. 2010; 316(20): 3501
[Pubmed]  [Google Scholar] [DOI]
43 Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy
Sierra, J.R., Cepero, V., Giordano, S.
Molecular Cancer. 2010; 9(art ): 75
[Pubmed]  [Google Scholar]
44 Liver Regeneration after Partial Hepatectomy
George K. Michalopoulos
The American Journal of Pathology. 2010; 176(1): 2
[Pubmed]  [Google Scholar] [DOI]
45 Targeting of Both the c-Met and EGFR Pathways Results in Additive Inhibition of Lung Tumorigenesis in Transgenic Mice
Laura P. Stabile,Mary E. Rothstein,Phouthone Keohavong,Diana Lenzner,Stephanie R. Land,Autumn L. Gaither-Davis,K. Jin Kim,Naftali Kaminski,Jill M. Siegfried
Cancers. 2010; 2(4): 2153
[Pubmed]  [Google Scholar] [DOI]
46 The Effect of Gefitinib on Immune Response of Human Peripheral Blood Monocyte-Derived Dendritic Cells
Jin Hoon Cho, Mi Hyun Kim, Kwang Ha Lee, Ki Uk Kim, Doo Soo Jeon, Hye Kyung Park, Yun Seong Kim, Min Ki Lee, Soon Kew Park
Tuberculosis and Respiratory Diseases. 2010; 69(6): 456
[HTML Full text]  [Google Scholar] [DOI]
47 Does hepatocyte growth factor/c-Met signal play synergetic role in lung cancer?
Xiangdong Wang, Ka Li, Hong Chen, Diane Wang, Yong Zhang, Chunxue Bai
Journal of Cellular and Molecular Medicine. 2010; 14(4): 833
[HTML Full text]  [Google Scholar] [DOI]
48 Liver regeneration after partial hepatectomy: Critical analysis of mechanistic dilemmas
Michalopoulos, G.K.
American Journal of Pathology. 2010; 176(1): 2-13
[Pubmed]  [Google Scholar]
49 Targeting of both the c-Met and EGFR pathways results in additive inhibition of lung tumorigenesis in transgenic mice
Stabile, L.P. and Rothstein, M.E. and Keohavong, P. and Lenzner, D. and Land, S.R. and Gaither-Davis, A.L. and Kim, K.J. and Kaminski, N. and Siegfried, J.M.
Cancers. 2010; 2(4): 2153-2170
[Pubmed]  [Google Scholar]
50 Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibition
Corso, S. and Ghiso, E. and Cepero, V. and Sierra, J.R. and Migliore, C. and Bertotti, A. and Trusolino, L. and Comoglio, P.M. and Giordano, S.
Molecular Cancer. 2010; 9(121)
[Pubmed]  [Google Scholar]
51 The combination of multiple receptor tyrosine kinase inhibitor and mammalian target of rapamycin inhibitor overcomes erlotinib resistance in lung cancer cell lines through c-met inhibition
Nakachi, I. and Naoki, K. and Soejima, K. and Kawada, I. and Watanabe, H. and Yasuda, H. and Nakayama, S. and Yoda, S. and Satomi, R. and Ikemura, S. and Terai, H. and Sato, T. and Ishizaka, A.
Molecular Cancer Research. 2010; 8(8): 1142-1151
[Pubmed]  [Google Scholar]
52 Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy
Sierra, J.R. and Cepero, V. and Giordano, S.
Molecular Cancer. 2010; 9(75)
[Pubmed]  [Google Scholar]
53 Hepatic growth factor (HGF) inhibits cigarette smoke extract induced apoptosis in human bronchial epithelial cells
Togo, S., Sugiura, H., Nelson, A., Kobayashi, T., Wang, X., Kamio, K., Kawasaki, S., (...), Liu, X.
Experimental Cell Research. 2010; 316(20): 3501-3511
[Pubmed]  [Google Scholar]
54 MET and KRAS gene amplification mediates acquired resistance to MET tyrosine kinase inhibitors
Cepero, V., Sierra, J.R., Corso, S., Ghiso, E., Casorzo, L., Perera, T., Comoglio, P.M., Giordano, S.
Cancer Research. 2010; 70(19): 7580-7590
[Pubmed]  [Google Scholar]
55 The combination of multiple receptor tyrosine kinase inhibitor and mammalian target of rapamycin inhibitor overcomes erlotinib resistance in lung cancer cell lines through c-met inhibition
Nakachi, I., Naoki, K., Soejima, K., Kawada, I., Watanabe, H., Yasuda, H., Nakayama, S., (...), Ishizaka, A.
Molecular Cancer Research. 2010; 8(8): 1142-1151
[Pubmed]  [Google Scholar]
56 Activation of HER family members in gastric carcinoma cells mediates resistance to MET inhibition
Corso, S., Ghiso, E., Cepero, V., Sierra, J.R., Migliore, C., Bertotti, A., Trusolino, L., (...), Giordano, S.
Molecular Cancer. 2010; 9(art ): 121
[Pubmed]  [Google Scholar]
57 Tyrosine kinases as molecular targets to inhibit cancer progression and metastasis
Cepero, V., Sierra, J.R., Giordano, S.
Current Pharmaceutical Design. 2010; 16(12): 1396-1409
[Pubmed]  [Google Scholar]
58 Discovery of aminopyridines substituted with benzoxazole as orally active c-Met kinase inhibitors
Sung Yun Cho, Sun-Young Han, Jae Du Ha, Jae Wook Ryu, Chong Ock Lee, Heejung Jung, Nam Sook Kang, Hyoung Rae Kim, Jong Sung Koh, Jongkook Lee
Bioorganic & Medicinal Chemistry Letters. 2010; 20(14): 4223
[HTML Full text]  [Google Scholar] [DOI]
59 Effects of bufalin on the proliferation of human lung cancer cells and its molecular mechanisms of action
Yongtao Jiang, Ying Zhang, Jinling Luan, Huiying Duan, Feng Zhang, Kazumi Yagasaki, Guoying Zhang
Cytotechnology. 2010; 62(6): 573
[HTML Full text]  [Google Scholar] [DOI]
60 Targeted therapies for non-small cell lung cancer
Dempke, W.C.M., Suto, T., Reck, M.
Lung Cancer. 2010; 67(3): 257-274
[Pubmed]  [Google Scholar]
61 Liver regeneration after partial hepatectomy: Critical analysis of mechanistic dilemmas
Michalopoulos, G.K.
American Journal of Pathology. 2010; 176(1): 2-13
[Pubmed]  [Google Scholar]
62 MET/PKCβ expression correlate with metastasis and inhibition is synergistic in lung cancer
Faoro, L., Cervantes, G., Ferguson, B., Seiwert, T., Yala, S., Vigneswaran, W., Westerhoff, M., (...), Salgia, R.
Journal of Carcinogenesis. 2009; 8(art 15)
[Pubmed]  [Google Scholar]
63 Role of c-Met in Cancer: Emphasis on Lung Cancer
Salgia R
SEMINARS IN ONCOLOGY. 2009 ; 36 (2): S52-S58
[Pubmed]  [Google Scholar]
64 Effects of hepatocyte growth factor on the expression and phosphorylation of focal adhesion kinase in SMMC-7721 cells
Su, R.-J., Li, Z., Li, H.-D., Song, H.-J., Cheng, L.-F.
World Chinese Journal of Digestology. 2009; 17(20): 2070-2073
[Pubmed]  [Google Scholar]
65 MET/PKCβ expression correlate with metastasis and inhibition is synergistic in lung cancer
Faoro, L. and Cervantes, G. and Ferguson, B. and Seiwert, T. and Yala, S. and Vigneswaran, W. and Westerhoff, M. and Tretiakova, M. and Ferguson, M. and Moura, G. and Husain, A. and Vokes, E. and Salgia, R.
Journal of Carcinogenesis. 2009; 8(15)
[Pubmed]  [Google Scholar]
66 Role of c-Met in Cancer: Emphasis on Lung Cancer
Ravi Salgia
Seminars in Oncology. 2009; 36: S52
[Pubmed]  [Google Scholar] [DOI]
67 Synergistic proapoptotic effects of the two tyrosine kinase inhibitors pazopanib and lapatinib on multiple carcinoma cell lines
Oncogene. 2009; 28(48): 4249
[HTML Full text]  [Google Scholar] [DOI]

 

Read this article